- Home
- ACNB vs MXCT Comparison
ACNB vs MXCT Comparison
Compare ACNB & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- MXCT
- Stock Information
- Founded
- ACNB 1857
- MXCT 1999
- Country
- ACNB United States
- MXCT United States
- Employees
- ACNB 413
- MXCT N/A
- Industry
- ACNB Major Banks
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACNB Finance
- MXCT Health Care
- Exchange
- ACNB Nasdaq
- MXCT Nasdaq
- Market Cap
- ACNB 401.0M
- MXCT 398.3M
- IPO Year
- ACNB N/A
- MXCT 2021
- Fundamental
- Price
- ACNB $47.05
- MXCT $3.51
- Analyst Decision
- ACNB Buy
- MXCT Strong Buy
- Analyst Count
- ACNB 2
- MXCT 3
- Target Price
- ACNB $37.00
- MXCT $8.67
- AVG Volume (30 Days)
- ACNB 13.5K
- MXCT 353.2K
- Earning Date
- ACNB 10-24-2024
- MXCT 11-06-2024
- Dividend Yield
- ACNB 2.69%
- MXCT N/A
- EPS Growth
- ACNB N/A
- MXCT N/A
- EPS
- ACNB 3.44
- MXCT N/A
- Revenue
- ACNB $105,241,000.00
- MXCT $45,599,000.00
- Revenue This Year
- ACNB N/A
- MXCT N/A
- Revenue Next Year
- ACNB $20.49
- MXCT $23.47
- P/E Ratio
- ACNB $13.81
- MXCT N/A
- Revenue Growth
- ACNB N/A
- MXCT 19.85
- 52 Week Low
- ACNB $30.24
- MXCT $3.15
- 52 Week High
- ACNB $50.72
- MXCT $5.55
- Technical
- Relative Strength Index (RSI)
- ACNB 59.80
- MXCT 38.39
- Support Level
- ACNB $41.03
- MXCT $3.50
- Resistance Level
- ACNB $50.72
- MXCT $4.15
- Average True Range (ATR)
- ACNB 1.18
- MXCT 0.21
- MACD
- ACNB 0.51
- MXCT 0.01
- Stochastic Oscillator
- ACNB 56.55
- MXCT 14.81
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Bank which generates the majority of the revenue provides banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.